Relapsing neuropathy in an 18-year-old woman

Lancet Neurology

Volumn 6, Issue 2, 2007, Pages 192-198

  Ginsberg, Lionel ^a   Schapira, Anthony HV ^a   Taanman, Jan Willem ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL SYMPTOM; GUILLAIN BARRE SYNDROME; HUMAN; LIMB WEAKNESS; MNGIE SYNDROME; NERVE CONDUCTION; NEUROLOGIC DISEASE; NEUROPATHY; PARESTHESIA; PRIORITY JOURNAL; PTOSIS; RELAPSE; REVIEW;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; GASTROINTESTINAL DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MITOCHONDRIAL ENCEPHALOMYOPATHIES; MODELS, MOLECULAR; MUTATION; RECURRENCE; THYMIDINE PHOSPHORYLASE;

EID: 33846256616     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(07)70033-9     Document Type: Review

References (49)

1. Ginsberg L. Metabolic, endocrine and toxic disorders. In: Warlow C. (Ed). The Lancet handbook of treatment in neurology (2006), Elsevier, Edinburgh 339-363
2. Harding A. Vitamin E and the nervous system. Crit Rev Neurobiol 3 (1987) 89-103
3. Chin R., Sander H., Brannagan T., et al. Celiac neuropathy. Neurology 60 (2003) 1581-1585
4. Wills A., and Unsworth D. The neurology of gluten sensitivity: separating the wheat from the chaff. Curr Opin Neurol 15 (2002) 519-523
5. Anderson M. Neurology of Whipple's disease. J Neurol Neurosurg Psychiatry 68 (2000) 2-5
6. Desnick R., Ioannou Y., and Eng C. α galactosidase A deficiency: Fabry disease. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8 edn. vol. 2 (2001), McGraw-Hill, New York 3733-3774
7. Mehta A., Ricci R., Widmer U., et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34 (2004) 236-242
8. Crutchfield K., Patronas N., Dambrosia J., et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50 (1998) 1746-1749
9. Deegan P., Baehner A., Barba Romero M., Hughes D., Kampmann C., and Beck M. Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet 43 (2006) 347-352
10. Ginsberg L. Specific painful neuropathies. In: Cervero F., and Jensen T. (Eds). Handbook of clinical neurology, vol 81 Pain (2006), Elsevier, Edinburgh 635-652
11. Kissel J., Slivka A., Warmolts J., and Mendell J. The clinical spectrum of necrotizing angiopathy of the peripheral nervous system. Ann Neurol 18 (1985) 251-257
12. Churg J., and Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27 (1951) 277-301
13. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41 (1991) 617-618
14. Kissel J., and Mendell J. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Mendell J., Kissel J., and Cornblath D. (Eds). Diagnosis and management of peripheral nerve disorders (2001), Oxford University Press, Oxford 173-191
15. Donaghy M., and Earl C. Ocular palsy preceding chronic relapsing polyneuropathy by several weeks. Ann Neurol 17 (1985) 49-50
16. Arroyo J., and Horton J. Acute, painful, pupil-involving third nerve palsy in chronic inflammatory demyelinating polyneuropathy. Neurology 45 (1995) 846-847
17. Mendell J., Kolkin S., Kissel J., Weiss K., Chakeres D., and Rammohan K. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 37 (1987) 1291-1294
18. Feasby T., Hahn A., Koopman W., and Lee D. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology 40 (1990) 476-478
19. Moser H. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120 (1997) 1485-1508
20. Hanna M., and Cudia P. Peripheral nerve diseases associated with mitochondrial respiratory chain dysfunction. In: Dyck P., and Thomas P. (Eds). Peripheral neuropathy. 4 edn. vol. 2 (2005), Elsevier Saunders, Philadelphia 1937-1949
21. Martí R., Spinazzola A., Tadesse S., Nishino I., Nishigaki Y., and Hirano M. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 50 (2004) 120-124
22. Hagiwara K., Stenman G., Honda H., et al. Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol Cell Biol 11 (1991) 2125-2132
23. Bedlack R., Vu T., Hammans S., et al. MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 29 (2004) 364-368
24. Nishino I., Spinazzola A., and Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 (1999) 689-692
25. Norman R., Barry S., Bate M., et al. Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor. Structure 12 (2004) 75-84
26. Schapira A. Mitochondrial diseases. Lancet 368 (2006) 70-82
27. Zeviani M., Spinazzola A., and Carelli V. Nuclear genes in mitochondrial disorders. Curr Opin Genet Dev 13 (2003) 262-270
28. Taanman J.-W., Muddle J., and Muntau A. Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum Mol Genet 12 (2003) 1839-1845
29. Brown N., and Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J 334 (1998) 1-8
30. Nishino I., Spinazzola A., Papadimitriou A., et al. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47 (2000) 792-800
31. Ferraro P., Pontarin G., Crocco L., Fabris S., Reichard P., and Bianchi V. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280 (2005) 24472-24480
32. Spinazzola A., and Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 354 (2005) 162-168
33. Van Goethem G., Schwartz M., Löfgren A., Dermaut B., Van Broeckhoven C., and Vissing J. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 11 (2003) 547-549
34. Naviaux R., and Nguyen K. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 55 (2004) 706-712
35. Winterthun S., Ferrari G., He L., et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase γ mutations. Neurology 64 (2005) 1204-1208
36. Luoma P., Melberg A., Rinne J., et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study. Lancet 364 (2004) 875-882
37. Davidzon G., Greene P., Mancuso M., et al. Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59 (2006) 859-862
38. Van Goethem G., Dermaut B., Löfgren A., Martin J.-J., and Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28 (2001) 211-212
39. Longley M., Clark S., Yu Wai Man C., et al. Mutant POLG2 disrupts DNA polymerase γ subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 78 (2006) 1026-1034
40. Fadic R., Russell J., Vedanarayanan V., Lehar M., Kuncl R., and Johns D. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 49 (1997) 39-45
41. Van Goethem G., Martin J., Dermaut B., et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13 (2003) 133-142
42. Hara H., Wakayama Y., Kouno Y., Yamada H., Tanaka M., and Ozawa T. Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. J Neurol Neurosurg Psychiatry 57 (1994) 1545-1546
43. Dyck P., Swanson C., Low P., Bartleson J., and Lambert E. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 57 (1982) 239-246
44. Ginsberg L., Malik O., Kenton A., et al. Coexistent hereditary and inflammatory neuropathy. Brain 127 (2004) 193-202
45. Martini R., and Toyka K. Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3 (2004) 457-465
46. Schröder J., Bohl J., and von Bardeleben U. Changes of the ratio between myelin thickness and axon diameter in human developing sural, femoral, ulnar, facial, and trochlear nerves. Acta Neuropathol (Berl) 76 (1988) 471-483
47. Hirano M., Martí R., Casali C., et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67 (2006) 1458-1460
48. Chinnery P., Majamaa K., Turnbull D., and Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2006) CD004426
49. Giordano C., Sebastiani M., Plazzi G., et al. Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 130 (2006) 893-901